| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 2020-12 | PURCHASE | 2020-12 | 181 | 157 | 24 | ||||
| UNITED STATES TREASURY BILL | 2020-12 | PURCHASE | 2020-12 | 2,000 | 2,000 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| UBS BROKERAGE | 11,469 | 11,469 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| UBS BROKERAGE | 68,579 | 68,579 |
| Description | Amount |
|---|---|
| UNREALIZED GAINS | 976 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT ADVISORY FEES | 82 | 82 |